DI
BMY icon

DFPG Investments’s Bristol-Myers Squibb BMY Stock Holding History

DFPG Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$802K Sell
15,328
-204
-1% -$10.7K 0.06% 281
2023
Q3 		$783K Sell
15,532
-3,033
-16% -$186K 0.07% 247
2023
Q2 		$1.15M Sell
18,565
-9,888
-35% -$663K 0.1% 199
2023
Q1 		$1.97M Buy
28,453
+12,124
+74% +$855K 0.21% 108
2022
Q4 		$1.17M Buy
+16,329
New +$1.23M 0.19% 121

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DFPG Investments's BMY Position: Q4 2023 in Review

DFPG Investments reduced its Bristol-Myers Squibb (BMY) stake by 1.3% in Q4 2023, selling an estimated $10.7K and leaving 15,328 shares worth $802K. The position accounts for 0.06% of the portfolio, ranked #281.

DFPG Investments first reported a position in BMY in Q4 2022 and has held it in 5 quarters since. The position peaked at $1.97M in Q1 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • DFPG Investments held 15,328 shares of Bristol-Myers Squibb worth $802K as of Q4 2023.
  • DFPG Investments sold 204 Bristol-Myers Squibb shares in Q4 2023, an estimated $10.7K.
  • Bristol-Myers Squibb made up 0.06% of DFPG Investments's portfolio in Q4 2023, its #281 holding.
  • DFPG Investments first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 5 quarters since.
  • DFPG Investments's Bristol-Myers Squibb position peaked at $1.97M in Q1 2023.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.